Clinical Trials Directory

Trials / Completed

CompletedNCT03227458

DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
152 (actual)
Sponsor
University of Colorado, Denver · Academic / Other
Sex
Female
Age
55 Years – 85 Years
Healthy volunteers
Accepted

Summary

To determine whether the musculoskeletal adaptations to bone-loading exercise can be significantly augmented in older women (aged 60-85) with low bone mass (osteopenia; T-scores \<-1.0 and \>-2.5) or moderate osteoporosis (T-scores \< -2.5 and \>= -3.0) and by restoring serum DHEAS to young adult levels by oral DHEA replacement.

Detailed description

This will be the first study to measure changes in areal bone mineral density (aBMD) and fat-free mass (FFM) in response to dehydroepiandrosterone (DHEA) alone and combined with exercise in postmenopausal women. The body of evidence from carefully executed Randomized Controlled Studies (RCTs) provides support for DHEA therapy to increase aBMD and FFM in older women. Less is known about whether DHEA therapy enhances the effects of exercise on the aging musculoskeletal system when an appropriate mechanical stimulus is applied.

Conditions

Interventions

TypeNameDescription
OTHERDHEAParticipants will take 1 study pill (50 mg DHEA) daily for 36 weeks.
OTHERPlaceboParticipants will take placebo daily for 36 weeks.
BEHAVIORALExercisebone-loading exercise on 3 days per week for 38 weeks

Timeline

Start date
2018-02-12
Primary completion
2024-06-19
Completion
2024-06-19
First posted
2017-07-24
Last updated
2024-12-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03227458. Inclusion in this directory is not an endorsement.